Business context and reporting period
Photronics, Inc. manufactures photomasks used in semiconductor and flat-panel-display (FPD) production. This unaudited Form 10-Q covers the fiscal first quarter ended January 31, 2016; the comparable quarter ended February 1, 2015. Figures below are in U.S. dollars, generally millions unless noted.
Financial performance and liquidity
| Metric | Q1 2016 | Q1 2015 |
|---|---|---|
| Net sales | $130.0 | $123.5 |
| Gross profit / margin | $35.4 / 27.3% | $28.2 / 22.8% |
| Operating income / margin | $17.5 / 13.5% | $11.6 / 9.4% |
| Net income | $23.5 | $7.1 |
| Net income attributable to Photronics shareholders | $21.0 | $3.8 |
| Basic / diluted EPS | $0.31 / $0.28 | $0.06 / $0.06 |
| Cash from operations | $43.4 | $22.3 |
| Capital expenditure payments | $21.5 | $40.4 |
Operating cash flow less capital expenditure payments was approximately $21.8 million. Cash and cash equivalents were $231.4 million at January 31, 2016, up from $205.9 million at November 1, 2015; working capital was $206.6 million. Cash held by foreign subsidiaries was $117.6 million, most of which management considers indefinitely reinvested.
Total borrowings were $130.2 million, including $64.0 million classified as current, primarily reflecting $57.5 million of 3.25% convertible notes due April 2016. The company had no credit-facility borrowings and $50 million available under its facility. The filing reports total cash exceeding total borrowings by approximately $101.3 million. The facility’s financial covenants were met.
Material changes versus the prior comparable period
- Sales increased 5.2%. FPD sales rose 37.0% to $30.2 million, while IC sales declined 1.7% to $99.8 million. High-end product revenue increased to $65.1 million from $51.7 million.
- Gross margin improved 4.5 percentage points, which management primarily attributed to higher high-end sales. Operating income increased about 52% despite higher R&D spending, up 21.8% to $5.7 million.
- Shareholder net income included an $8.8 million gain from selling a minority investment; there was no comparable gain in Q1 2015. The 13.6% effective tax rate, versus 30.5%, was affected by the gain and jurisdictional mix of earnings.
- Operating cash flow rose to $43.4 million, primarily reflecting higher net income. Capital expenditure payments fell to $21.5 million from $40.4 million.
- Foreign-currency translation losses were $21.1 million, contributing to a $21.0 million comprehensive loss before noncontrolling interests despite positive net income.
Outlook, commentary, and risks
Management provided no numerical revenue or earnings guidance. It expects much of future revenue growth to come from Asia and anticipates additional North American growth from advanced technology available under the Micron license. The company expects available cash, operating cash generation, and its credit facility to fund planned needs for at least the next 12 months, while noting that financing beyond those resources may not be available on favorable terms.
The MP Mask joint venture is scheduled not to renew after May 5, 2016. Micron is expected to purchase Photronics’ interest based on its ownership share of net book value, approximately $93 million as of January 18, 2016; management does not expect a significant gain or loss. A new Micron supply agreement begins May 6, 2016, for an initial one-year term, subject to mutually agreeable renewals. Photronics will be Micron’s majority outsource supplier under the agreement.
Key risks include semiconductor and display industry cyclicality, customer design activity and product mix, high fixed costs and utilization, currency movements, and the timing and cost of capital spending. The company cited first-quarter seasonality from North American and European holidays and possible Asian New Year effects. A 10% adverse currency movement was estimated to produce a $6.9 million unrealized pretax loss; management did not expect such a movement to materially affect results or cash flows. Capital equipment commitments were approximately $9 million. The filing says ordinary-course claims are not expected to have a material effect; it reports no material change to previously disclosed risk factors.
Important facts for investors to verify
- Whether the April 2016 $57.5 million convertible-note maturity is repaid, converted, or refinanced, and the resulting dilution and liquidity impact.
- Completion, timing, and proceeds of the MP Mask interest sale, and the terms and renewal prospects of the Micron supply agreement.
- Whether high-end IC and FPD demand and improved gross margins persist, given lower mainstream IC sales and the business’s high fixed-cost structure.
- How much of reported earnings reflects recurring operations versus the one-time $8.8 million investment gain and foreign-currency effects.
- Use and accessibility of overseas cash, future capital spending, and compliance with credit-facility covenants.